Isoptin (Verapamil Hydrochloride)

Verapamil blocks L‑type calcium channels in vascular smooth muscle and cardiac tissue. This inhibition reduces calcium entry, causing arterial dilation, decreased myocardial contractility, and a prolonged refractory period in the atrioventricular node. The combined effects lower systemic vascular resistance, reduce cardiac workload, and slow abnormal electrical conduction, which together control blood pressure and heart rhythm.

The appropriate dose of Isoptin is individualized by the prescribing healthcare professional based on the patient’s specific condition, severity, renal and hepatic function, and response to therapy. Clinicians adjust the regimen to achieve therapeutic goals while monitoring for efficacy and safety; no fixed dosing schedule is provided here.

Verapamil is classified as pregnancy category B1, indicating that animal studies have not shown risk and there are no adequate human studies. It may be used during pregnancy only if the potential benefit justifies any potential risk to the fetus. Limited data are available for breastfeeding, so a risk‑benefit assessment should be performed by the prescriber.

To request Isoptin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will ask for trade or institutional credentials. After verification, the sales team provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Both verapamil and diltiazem are non‑dihydropyridine calcium channel blockers, but verapamil has a stronger effect on cardiac conduction and contractility, making it more suitable for rhythm control. Diltiazem tends to have a milder impact on heart rate and is often preferred when a balanced antihypertensive and anti‑anginal effect is desired. Choice depends on the clinical indication and patient tolerance.

Isoptin should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Isoptin is administered orally, typically as a tablet taken with or without food as directed by a healthcare professional. The exact timing, frequency, and whether it should be taken with meals are determined by the prescriber based on the individual’s therapeutic needs and tolerability.

The most serious risks include severe bradycardia, heart block, and profound hypotension, which can lead to syncope or shock. These events may require immediate medical intervention. Patients with existing conduction abnormalities or severe heart failure are particularly vulnerable, and close monitoring is essential when initiating therapy.

Isoptin is contraindicated in patients with second‑ or third‑degree atrioventricular block without a functioning pacemaker, severe left ventricular dysfunction or overt heart failure, and in those with known hypersensitivity to verapamil or any excipients. Caution is also advised for individuals with significant hepatic impairment or concurrent use of interacting medications.